ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch ...
Unfortunately, there isn't an enzyme for many reactions we would sorely like to catalyze—things like digesting plastics or ...
D Molecular Therapeutics (NASDAQ:FDMT – Free Report) had its price target decreased by Chardan Capital from $39.00 to $30.00 in a report released on Tuesday,Benzinga reports. Chardan Capital currently ...